Tracells

Pioneering non-invasive stool tests leveraging patient transcriptome and an AI-driven classifier for advanced transcriptomics and precise diagnostics of inflammatory bowel diseases.

Health Tech & Life Sciences
Active
Pre-Seed Yokne'am Illit, Israel Founded 2024
Last updated 2026-07-20
Total raised
$1.0M
Last: Grant 2024-04
Stage
Pre-Seed
Founded
2024
Headcount
7
HQ
Yokne'am Illit, Israel
Sector
Health Tech & Life Sciences

About

Tracells is a biotechnology company that emerged as a spinoff from the Weizmann Institute of Science. The company is dedicated to revolutionizing gastrointestinal disease diagnostics and therapeutics by developing a reliable non-invasive solution to predict colonoscopy outcomes and diagnose bowel inflammation. Their cutting-edge technology utilizes human RNA molecular and computational biology to analyze the human transcriptome of stool samples, accurately diagnosing the severity, location, and molecular signatures of bowel inflammation. Tracells' platform technology also holds promise for tackling various gastrointestinal ailments, including Celiac disease, colorectal cancer (CRC), and irritable bowel syndrome (IBS). The company holds a licensed patent (WO/2023/002491) granted by the Weizmann Institute of Science & Sheba Medical Center in Israel.

Funding history · 2 rounds · $1.0M total

2024-03
Grant Undisclosed
2024-03
Pre-Seed $1.0M
★ G.O Innovation

Headcount over time

From 4 (2024-03) to 7 (2025-10) · +3 (+75%) · 5 points · source: Finder history + radar grounding
70 2024-03 2025-10

Q&A

What is Tracells' primary focus?
Tracells specializes in non-invasive diagnostic testing for inflammatory bowel diseases (IBD) using advanced RNA transcriptomics and AI-driven classifiers.
When was Tracells founded?
Tracells was founded in January 2024.
What is Tracells' current funding stage?
Tracells is currently in the Pre-Seed funding stage.
Who are the co-founders of Tracells?
The co-founders of Tracells are Maya Hanum, who serves as Co-Founder & CEO, and Yotam Harnik, who is the Co-Founder & CTO.
What is the total amount of funding Tracells has raised to date?
Tracells has raised a total of $1,000,000 USD.
Which investor participated in Tracells' April 2024 funding round?
G.O Innovation participated in Tracells' funding round in April 2024.
Did Tracells receive any grants?
Yes, Tracells received a grant from the Israel Innovation Authority in April 2024.

Team · 3

Maya Kahan-Hanum, PhD
Founder · Co-Founder & CEO
Yotam Harnik, PhD
Founder · Co-Founder & CTO
Prof. Shalev Itzkovitz
Founder · Scientific Founder & Board Member

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Tags

pharmaceuticalsnon-invasivediagnosticsinflammatory-diseases
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitetracells.com/
LinkedInlinkedin.com/company/101528832

Identifiers & details

Legal nameTracells Ltd.
Founded2024-1
Employees (exact)7

Radar intelligence

Patents

EPO1

Publications (Crossref)

Works2

Web history (Wayback)

Domaintracells.com

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516912649
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2024-01-04
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2026
Active charges / liens1
Registry events7 — shares_capital (1), charge (1), annual_report (4), people (1)
Registered addressהתנופה 3 יקנעם עילית

Recent registry events

DateEvent
2026-03-15שינוי בהרכב הון - מניות-פיצול מניה
2026-05-14רישום שעבוד
2026-03-11דו~ח שנתי-הקצאת מניות
2026-03-11עדכון בעלי תפקידים
2026-03-11דו~ח שנתי-הוספת דירקטור
2026-03-11דו~ח שנתי-הסרת דירקטור
2026-03-11דו~ח שנתי-עדכון כתובת